Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parkes

Showing results (71-80 of 177) with videos related to

Pageof 18
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1976
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopaJ D Parkes, A G Debono, C D Marsden
Environmental Monitoring and Assessment|October 24, 2006
Inorganic nitrogen transformations in the treatment of landfill leachate with a high ammonium load: A case studyStephen D Parkes, Dianne F Jolley, Stephen R Wilson
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year periodN Quinn, D Parkes, I Janota, et al.
Lancet (London, England)|October 25, 1986
When should levodopa be started?N Quinn, P Critchley, D Parkes, et al.
Transplantation|December 2, 2016
Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant RejectionMichael D Parkes, Philip F Halloran, Luis G Hidalgo
Lancet (London, England)|December 29, 1973
A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa aloneC D Marsden, J D Parkes, J E Rees
Experimental Cell Research|March 15, 1997
ES cell cycle rates affect gene targeting frequenciesG B Udy, B D Parkes, D N Wells
Equine Veterinary Journal|January 1, 1978
Foetal electrocardiography in the mareC M Colles, R D Parkes, C J May
Lancet (London, England)|February 28, 1976
Letter: Growth-hormone responses in Parkinson's diseaseJ D Parkes, A G Debono, C D Marsden
Lancet (London, England)|May 23, 1992
The narcolepsy susceptibility geneM Dahlitz, R Vaughan, K Kayed, et al.
Pageof 18

Showing results (71-80 of 177) with videos related to

Sort By:
Pageof 18
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1976
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopaJ D Parkes, A G Debono, C D Marsden
Environmental Monitoring and Assessment|October 24, 2006
Inorganic nitrogen transformations in the treatment of landfill leachate with a high ammonium load: A case studyStephen D Parkes, Dianne F Jolley, Stephen R Wilson
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year periodN Quinn, D Parkes, I Janota, et al.
Lancet (London, England)|October 25, 1986
When should levodopa be started?N Quinn, P Critchley, D Parkes, et al.
Transplantation|December 2, 2016
Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant RejectionMichael D Parkes, Philip F Halloran, Luis G Hidalgo
Lancet (London, England)|December 29, 1973
A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa aloneC D Marsden, J D Parkes, J E Rees
Experimental Cell Research|March 15, 1997
ES cell cycle rates affect gene targeting frequenciesG B Udy, B D Parkes, D N Wells
Equine Veterinary Journal|January 1, 1978
Foetal electrocardiography in the mareC M Colles, R D Parkes, C J May
Lancet (London, England)|February 28, 1976
Letter: Growth-hormone responses in Parkinson's diseaseJ D Parkes, A G Debono, C D Marsden
Lancet (London, England)|May 23, 1992
The narcolepsy susceptibility geneM Dahlitz, R Vaughan, K Kayed, et al.
Pageof 18